| Value | ₹0.30 Cr |
|---|
BSE filing, NSE: VGUARD. Summary written from the filing by ALFA Finder's alert engine.
V-Guard Industries Ltd: key numbers
- Share price
- ₹304.50
- Market cap
- ₹13,309 Cr
- Revenue (annual)
- ₹5,966 Cr
- Net profit (annual)
- ₹308.3 Cr
- P/E (TTM)
- 32.4×Sector 42.6×
- Promoter holding
- 53.21%-0.01% QoQ
- FII holding
- 13.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from V-Guard Industries Ltd
All →V-Guard Industries Annual General Meeting
V-Guard seeks shareholder approval via postal ballot to appoint Kurian Puthenpurayil John as independent director for five years. E-voting runs 7 November to 6 December 2026.
V-Guard Industries Earnings Call Transcript: Key Takeaways
V-Guard delivered strong volume growth but faced margin compression from input costs and a pricing lag.
- Call
- Guides 15% growth
V-Guard Industries Investor Presentation: Key Takeaways
V-Guard delivered robust Q2 FY27 performance with consolidated revenue growing 38.2% YoY to ₹1,852.89 Cr and PAT rising 71% to ₹111.67 Cr, driven by strong growth across all business segments.
V-Guard Industries Management Change
V-Guard Industries appointed Mr Kurian Puthenpurayil John as Non-Executive Independent Director. He is a chartered accountant with corporate governance and investment experience.
V-Guard Industries Q2 FY27 Results: Net Profit ₹111.7 Cr, Up 71.1% YoY
V-Guard Industries Ltd reported revenue from operations of ₹1,853 Cr (+38.2% YoY) and net profit of ₹111.7 Cr (+71.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹111.7 Cr · +71.1% YoY
V-Guard Industries Employee Stock Options
V-Guard's committee approved a grant of 16,747 ESOS 2013 options on October 28, 2026. Options vest over up to four years, with a ₹1 exercise price.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr